Émilie Indersie

8PUBLICATIONS
106CO-AUTHORS
Molecular targetsSocial epidemiologyHaematological tumoursEpidemiological methodsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Feb 24, 2026
EZH2 is a key prognostic marker and therapeutic target in aggressive and proliferative hepatoblastoma.

Fatma Zohra Khoubai, Alexia Calovoulos, Hélène Guillorit

|Feb 11, 2026
GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells.

Sini M Kinnunen, Katja Eloranta, Marjut Pihlajoki

|Sep 26, 2025
Endometriosis Diagnostic Delay and Its Correlates: Results from the ComPaRe-Endometriosis Cohort.

Zélia Breton, Solène Gouesbet, Emilie Indersie

|Apr 26, 2025
Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma.

Lea Amelie Jung, Salih Demir, Alina Hotes

|Jan 29, 2024
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.

Salih Demir, Negin Razizadeh, Emilie Indersie

Pageof 2

Frequent Collaborators

4 joint publications

Stefano Cairo

2 joint publications

Salih Demir

2 joint publications

Roland Kappler

1 joint publications

Anthony Brown